Atrás
Rango del Día
$21.90
$23.52
Rango de 52 Semanas
$1.92
$31.18
Volumen
457,975
Promedio 50D / 200D
$25.15
/
$16.46
Cierre Anterior
$22.25
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.7 | 0.4 |
| P/B | 7.8 | 2.9 |
| ROE % | -84.7 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.5 | 0.2 |
Puntos Clave
Debt/Equity of 0.47 — conservative balance sheet
Negative free cash flow of -117.72M
PEG of 0.09 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-84.70%
ROIC-63.52%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.47
Current Ratio6.72
Interest Coverage0.00
Valoración
P/E Ratio
-6.68
P/B Ratio7.83
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -176.21M |
| ROE | -84.70% | ROA | -52.51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -117.72M |
| ROIC | -63.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.47 | Current Ratio | 6.72 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.68 | P/B Ratio | 7.83 |
| P/S Ratio | N/A | PEG Ratio | 0.09 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.18B | Enterprise Value | 1.08B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -176.21M | -260.49M | -333.82M | -266.99M | -133.10M |
| EPS (Diluted) | -3.35 | -4.97 | -6.39 | -5.16 | -2.91 |
| Gross Profit | -26.71M | -25.95M | -11.00M | -8.71M | -4.21M |
| Operating Income | -186.85M | -277.32M | -341.38M | -267.05M | -136.01M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 335.58M | 479.37M | 666.63M | 904.22M | 1.07B |
| Total Liabilities | 185.29M | 213.59M | 230.46M | 240.90M | 206.60M |
| Shareholders' Equity | 150.29M | 265.78M | 436.17M | 663.32M | 860.75M |
| Total Debt | 70.35M | 181.63M | 187.73M | 179.94M | 77.40M |
| Cash & Equivalents | 168.07M | 285.51M | 190.43M | 731.51M | 944.40M |
| Current Assets | 171.94M | 289.31M | 486.01M | 734.81M | 972.01M |
| Current Liabilities | 25.57M | 41.73M | 52.50M | 64.68M | 31.42M |